Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

12.31USD
11:22pm IST
Price Change (% chg)

$-0.10 (-0.81%)
Prev Close
$12.41
Open
$12.35
Day's High
$12.38
Day's Low
$12.28
Volume
874,123
Avg. Vol
2,375,861
52-wk High
$14.07
52-wk Low
$11.13

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.10
Market Cap (Mil.): $16,452.03
Shares Outstanding (Mil.): 1,325.71
Dividend: --
Yield (%): --

Financials

Search Stocks

Freshfields recruits veteran M&A partner from Shearman & Sterling

(This Sept. 15 story changes the 10th paragraph to reflect that Presser was not practicing law at Paine & Partners)

16 Sep 2014

Boston Scientific ordered to pay $73 million over mesh device

Sept 9 - A Texas jury has ordered Boston Scientific Corp to pay $73 million to a woman who said she suffered serious injuries from a transvaginal mesh device, the first loss for the device maker in one of thousands of suits over the products.

10 Sep 2014

Cyberonics device improves heart function after Boston flop

BARCELONA - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.

01 Sep 2014

Cyberonics device improves heart function after Boston flop

BARCELONA, Sept 1 - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.

01 Sep 2014

Boston Scientific nerve device no help in heart failure study

BARCELONA - A Boston Scientific device that stimulates the vagus nerve – a superhighway connecting the brain to the rest of the body - failed to help patients with heart failure in a mid-stage clinical trial.

30 Aug 2014

Boston Scientific nerve device no help in heart failure study

BARCELONA, Aug 30 - A Boston Scientific device that stimulates the vagus nerve - a superhighway connecting the brain to the rest of the body - failed to help patients with heart failure in a mid-stage clinical trial.

30 Aug 2014

Boston Scientific wins first trial over transvaginal mesh device

- A Massachusetts jury has cleared Boston Scientific Corp of selling dangerous and defective transvaginal mesh devices, in the first out of more than 20,000 lawsuits waiting to go to trial.

30 Jul 2014

Boston Scientific wins first trial over transvaginal mesh device

July 30 - A Massachusetts jury has cleared Boston Scientific Corp of selling dangerous and defective transvaginal mesh devices, in the first out of more than 20,000 lawsuits waiting to go to trial.

30 Jul 2014

UPDATE 2-Boston Scientific profit exceeds expectations as sales rise

July 24 - Boston Scientific Corp, which makes medical equipment, on Thursday reported a slightly higher-than-expected quarterly profit as improvements in its heart device business helped drive revenue up 4 percent.

24 Jul 2014

Boston Scientific reports profit as sales rise

July 24 - Boston Scientific, which makes medical equipment, on Thursday reported a better-than-expected profit as sales across all sectors including its large heart device business improved by 4 percent on a constant currency basis.

24 Jul 2014

Competitors

  Price Change
Abbott Laboratories (ABT.N) $43.29 -0.30
Medtronic, Inc. (MDT.N) $65.70 -0.52
St. Jude Medical, Inc. (STJ.N) $62.03 -0.21

Earnings vs. Estimates

Search Stocks